Future of the pharmacogenomics of calcineurin inhibitors in renal transplant patients

被引：6
|
作者：
Zhu, Huaijun [1 ]
Ge, Weihong [1 ]
机构：
[1] Nanjing Univ, Affiliated Nanjing Drum Tower Hosp, Sch Med, Dept Pharm, Nanjing 210008, Jiangsu, Peoples R China
来源：
PHARMACOGENOMICS | 2011年 / 12卷 / 11期
关键词：
calcineurin inhibitor; epigenetics; orphan nuclear receptor; pharmacogenomics; renal transplantation; REGULATED GENE-EXPRESSION; RECIPIENTS; THERAPY; PHARMACOKINETICS; PHARMACODYNAMICS; PERSPECTIVES; CELLS; CYP3A;
D O I：
10.2217/PGS.11.129
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1505 / 1508
页数：4
相关论文
共 50 条
  • [31] Repeated Daclizumab Administration to Delay the Introduction of Calcineurin Inhibitors in Heart Transplant Patients With Postoperative Renal Dysfunction
    Sanchez Lazaro, Ignacio J.
    Almenar Bonet, Luis
    Martinez Dolz, Luis
    Buendia Fuentes, Francisco
    Navarro Manchon, Josep
    Agueero Ramon-Llin, Jaime
    Vicente Sanchez, Jose Luis
    Salvador Sanz, Antonio
    REVISTA ESPANOLA DE CARDIOLOGIA, 2011, 64 (03): : 237 - 239
  • [32] Relationship between exposure variability to calcineurin inhibitors over time and onset of infection in renal transplant patients
    Villeneuve, C.
    Coubret, A.
    Gandia, P.
    Bouchet, S.
    Laroche, M. L.
    Rousseau, A.
    Marquet, P.
    Monchaud, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 : 28 - 28
  • [33] The efficacy and limitations of sirolimus conversion in liver transplant patients who develop renal dysfunction on calcineurin inhibitors
    Lam, P
    Yoshida, A
    Brown, K
    Abouljoud, M
    Bajjoka, I
    Dagher, F
    Moonka, DK
    DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (06) : 1029 - 1035
  • [34] ASSOCIATION OF SERUM ADIPONECTIN LEVELS WITH ENDOTHELIAL AND PLATELET FUNCTION IN RENAL TRANSPLANT PATIENTS USING CALCINEURIN INHIBITORS
    Sahin, Garip
    Akay, Olga Meltem
    Uslu, Sema
    Bal, Cengiz
    Yalcin, Ahmet Ugur
    Gulbas, Zafer
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 274 - 274
  • [35] The Efficacy and Limitations of Sirolimus Conversion in Liver Transplant Patients Who Develop Renal Dysfunction on Calcineurin Inhibitors
    Patrick Lam
    Atsushi Yoshida
    Kimberly Brown
    Marwan Abouljoud
    Iman Bajjoka
    Fadi Dagher
    Dilip K. Moonka
    Digestive Diseases and Sciences, 2004, 49 : 1029 - 1035
  • [36] Changes in Immunophenotypes After Conversion from Calcineurin Inhibitors to mTOR Inhibitors in Renal Transplant Recipients
    Yildiz, A.
    Cavusoglu, M.
    Adin, S.
    Caliskan, Y.
    Ozkok, A.
    Tasci, H.
    Deniz, G.
    Sariyar, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [37] Maximizing the clinical outcome with mTOR inhibitors in the renal transplant recipient: defining the role of calcineurin inhibitors
    Nashan, B
    TRANSPLANT INTERNATIONAL, 2004, 17 (06) : 279 - 285
  • [38] Lipid parameters, doses and blood levels of calcineurin inhibitors in renal transplant recipients
    Ciftci, H. S.
    Ayna, T. K. U.
    Caliskan, Y.
    Turkmen, A.
    Gurtekin, M.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 544 - 544
  • [39] THE EFFECT OF DIFFERENT CALCINEURIN INHIBITORS ON OXIDATIVE STRESS PARAMETERS IN RENAL TRANSPLANT RECIPIENTS
    Vlahovic, Predrag
    Vlahovic, Predrag
    Cvetkovic, Tatjana
    Djordjevic, Vidojko
    Velickovic-Radovanovic, Radmila
    Stefanovic, Nikola
    Ignjatovic, Aleksandra
    Sladojevic, Nikola
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 525 - 525
  • [40] Effect of Gene Polymorphisms on Pharmacokinetics of Calcineurin Inhibitors in Indian Renal Transplant Recipients
    Ashavaid, T. F.
    Raje, H. S.
    Shalia, K.
    Shah, B. V.
    THERAPEUTIC DRUG MONITORING, 2009, 31 (05) : 623 - 623
12345